Compound ID | 26
Class: Antimicrobial peptide
| Details of activity: | Negligible growth inhibition against all tested bacterial strains |
| Propensity to select resistant mutants: | Yes |
| Institute where first reported: | Peptide Research Laboratory, CSIR-Institute of Genomics and Integrative Biology, Delhi, India |
| Year first mentioned: | 2014 |
| Highest developmental phase: | Preclinical |
| Development status: | Experimental |
| External links: | |
| Citations: |
|